The success of Viagra initially sparked a boom for pharma, but recent shifts present a complicated scenario for investors. Off-patent alternatives are eating into profits, and continued litigation add further risk to https://janahppq258272.p2blogs.com/39573957/sildenafil-and-big-pharma-a-risky-bet